Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Resources>White Papers

  White Papers

A Scientific Approach to Good Manufacturing Practices

AMRI
More information
Bile Acids: Beyond Cholesterol Metabolism & Fat Absorption

Pacific Biomarkers
More information
Carbonylation using carbon monoxide: Novasep’s shortcut to complex str

Novasep Inc
More information
Competitive Edge

AMRI
More information
Evolving Intelligence

AMRI
More information
Expedite Development While Ensuring Successful Commercial Outcomes

AMRI
More information
Medical Affairs at the Centre of Life Sciences Innovation

Kinapse
More information
NonClinical Dose Formulation Analysis Method Validation and Sample Ana

SpringerLink
More information
Product Lifecycle Management: Maximizing profit and leveraging innovat

Vetter Pharma International GmbH
More information
<< 1 2 3 >>
showing results 1 to 9 of 19
Scientific News
NIH-supported Clinical Trials to Evaluate Long-acting, Injectable Antiretroviral Drugs
Both trials are expected to be completed in 2017.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Paramedics May be First Line of Treatment for Stroke
NIH study demonstrates feasibility of getting drugs to stroke patients faster.
Cancer Treatment with KU Origins Enters Second Clinical Trial
Cleave Biosciences has begun a Phase 1 clinical trial to evaluate CB-5083.
Ebola Vaccine Trial Opens in Liberia
Study led by Liberia-NIH partnership will test two experimental vaccines.
NIH Launches Tool to Advance Down Syndrome Research
Web portal will help approved professionals to plan clinical studies.
NIH Researchers Tackle Thorny Side of Gene Therapy
Pre-clinical studies in mice reveal ways to reduce cancer risk with modified treatment.
Early Blood Glucose Control Lengthens Life in People with Type 1 Diabetes
Reductions in diabetes complications resulting from tight glucose control translate into longer lifespans.
Oxford Vaccine Group Begins First Trial of New Ebola Vaccine
Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine regimen being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen).
GRP78 Protein Possible Universal Therapeutic Target
Drug combination including Viagra is effective tool in targeting the protein.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters